MFDS
- Status: likely_approved
🇰🇷 Hympavzi in South Korea
Hympavzi (MARSTACIMAB) regulatory status in South Korea.
Marketing authorisation
Hympavzi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in South Korea
Frequently asked questions
Is Hympavzi approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Hympavzi in South Korea?
Pfizer Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.